APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pet CBD (cannabidiol)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet CBD (cannabidiol) Market Outlook and Growth Opportunities 2026

Report ID 174024110419 December 2025198 pages

Choose your research edition.

Industry ResearchPet CBD (cannabidiol) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet CBD (cannabidiol) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pet CBD (cannabidiol) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet CBD (cannabidiol) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet CBD (cannabidiol) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pet CBD (cannabidiol) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet CBD (cannabidiol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet CBD (cannabidiol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet CBD (cannabidiol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet CBD (cannabidiol) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet CBD (cannabidiol) market include Trulieve Cannabis, Receptra Naturals, Pure Spectrum, PotNetwork Holdings, Pet Releaf, Kat's Naturals, Diamond CBD, Curaleaf and Choom Holdings, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet CBD (cannabidiol) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet CBD (cannabidiol) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet CBD (cannabidiol) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet CBD (cannabidiol) market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet CBD (cannabidiol) Segment by Company

Trulieve Cannabis

Receptra Naturals

Pure Spectrum

PotNetwork Holdings

Pet Releaf

Kat's Naturals

Diamond CBD

Curaleaf

Choom Holdings

Canna-Pet

Cannabis Strategies Acquisition

Bluebird Botanicals

Pet CBD (cannabidiol) Segment by Type

CBD Oil

CBD Jelly

CBD Capsule

Other

Pet CBD (cannabidiol) Segment by Application

Pet Sleep Disorder

Pet Anxiety

Pets Gastrointestinal Diseases

Other

Pet CBD (cannabidiol) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pet CBD (cannabidiol) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet CBD (cannabidiol) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet CBD (cannabidiol) significant trends, drivers, influence factors in global and regions.

6. To analyze Pet CBD (cannabidiol) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet CBD (cannabidiol) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet CBD (cannabidiol) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet CBD (cannabidiol).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet CBD (cannabidiol) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet CBD (cannabidiol) industry.

Chapter 3: Detailed analysis of Pet CBD (cannabidiol) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet CBD (cannabidiol) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet CBD (cannabidiol) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet CBD (cannabidiol) Industry Trends Table 2. Pet CBD (cannabidiol) Industry Drivers Table 3. Pet CBD (cannabidiol) Industry Opportunities and Challenges Table 4. Pet CBD (cannabidiol) Industry Restraints Table 5. Global Pet CBD (cannabidiol) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet CBD (cannabidiol) Revenue Share by Company (2021-2026) Table 7. Global Pet CBD (cannabidiol) Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Pet CBD (cannabidiol) Sales Volume Share by Company (2021-2026) Table 9. Global Pet CBD (cannabidiol) Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Pet CBD (cannabidiol) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet CBD (cannabidiol) Key Company Manufacturing Base & Headquarters Table 12. Global Pet CBD (cannabidiol) Company, Product Type & Application Table 13. Global Pet CBD (cannabidiol) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet CBD (cannabidiol) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of CBD Oil Table 18. Significant Companies of CBD Jelly Table 19. Significant Companies of CBD Capsule Table 20. Significant Companies of Other Table 21. Global Pet CBD (cannabidiol) Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Pet CBD (cannabidiol) Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Pet CBD (cannabidiol) Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Pet CBD (cannabidiol) Sales Volume Share by Type (2021-2026) Table 25. Global Pet CBD (cannabidiol) Sales Volume Share by Type (2027-2032) Table 26. Global Pet CBD (cannabidiol) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pet CBD (cannabidiol) Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Pet CBD (cannabidiol) Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Pet CBD (cannabidiol) Sales Value Share by Type (2021-2026) Table 30. Global Pet CBD (cannabidiol) Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pet Sleep Disorder Table 32. Significant Companies of Pet Anxiety Table 33. Significant Companies of Pets Gastrointestinal Diseases Table 34. Significant Companies of Other Table 35. Global Pet CBD (cannabidiol) Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Pet CBD (cannabidiol) Sales Volume by Application (2021-2026) & (Tons) Table 37. Global Pet CBD (cannabidiol) Sales Volume by Application (2027-2032) & (Tons) Table 38. Global Pet CBD (cannabidiol) Sales Volume Share by Application (2021-2026) Table 39. Global Pet CBD (cannabidiol) Sales Volume Share by Application (2027-2032) Table 40. Global Pet CBD (cannabidiol) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Pet CBD (cannabidiol) Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Pet CBD (cannabidiol) Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Pet CBD (cannabidiol) Sales Value Share by Application (2021-2026) Table 44. Global Pet CBD (cannabidiol) Sales Value Share by Application (2027-2032) Table 45. Global Pet CBD (cannabidiol) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 46. Global Pet CBD (cannabidiol) Sales by Region (2021-2026) & (Tons) Table 47. Global Pet CBD (cannabidiol) Sales Market Share by Region (2021-2026) Table 48. Global Pet CBD (cannabidiol) Sales by Region (2027-2032) & (Tons) Table 49. Global Pet CBD (cannabidiol) Sales Market Share by Region (2027-2032) Table 50. Global Pet CBD (cannabidiol) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Pet CBD (cannabidiol) Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Pet CBD (cannabidiol) Sales Value Share by Region (2021-2026) Table 53. Global Pet CBD (cannabidiol) Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Pet CBD (cannabidiol) Sales Value Share by Region (2027-2032) Table 55. Global Pet CBD (cannabidiol) Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Pet CBD (cannabidiol) Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Pet CBD (cannabidiol) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. Global Pet CBD (cannabidiol) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pet CBD (cannabidiol) Sales by Country (2021-2026) & (Tons) Table 60. Global Pet CBD (cannabidiol) Sales Market Share by Country (2021-2026) Table 61. Global Pet CBD (cannabidiol) Sales by Country (2027-2032) & (Tons) Table 62. Global Pet CBD (cannabidiol) Sales Market Share by Country (2027-2032) Table 63. Global Pet CBD (cannabidiol) Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Pet CBD (cannabidiol) Sales Value Market Share by Country (2021-2026) Table 65. Global Pet CBD (cannabidiol) Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Pet CBD (cannabidiol) Sales Value Market Share by Country (2027-2032) Table 67. Trulieve Cannabis Company Information Table 68. Trulieve Cannabis Business Overview Table 69. Trulieve Cannabis Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Trulieve Cannabis Pet CBD (cannabidiol) Product Portfolio Table 71. Trulieve Cannabis Recent Development Table 72. Receptra Naturals Company Information Table 73. Receptra Naturals Business Overview Table 74. Receptra Naturals Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Receptra Naturals Pet CBD (cannabidiol) Product Portfolio Table 76. Receptra Naturals Recent Development Table 77. Pure Spectrum Company Information Table 78. Pure Spectrum Business Overview Table 79. Pure Spectrum Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Pure Spectrum Pet CBD (cannabidiol) Product Portfolio Table 81. Pure Spectrum Recent Development Table 82. PotNetwork Holdings Company Information Table 83. PotNetwork Holdings Business Overview Table 84. PotNetwork Holdings Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. PotNetwork Holdings Pet CBD (cannabidiol) Product Portfolio Table 86. PotNetwork Holdings Recent Development Table 87. Pet Releaf Company Information Table 88. Pet Releaf Business Overview Table 89. Pet Releaf Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Pet Releaf Pet CBD (cannabidiol) Product Portfolio Table 91. Pet Releaf Recent Development Table 92. Kat's Naturals Company Information Table 93. Kat's Naturals Business Overview Table 94. Kat's Naturals Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Kat's Naturals Pet CBD (cannabidiol) Product Portfolio Table 96. Kat's Naturals Recent Development Table 97. Diamond CBD Company Information Table 98. Diamond CBD Business Overview Table 99. Diamond CBD Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Diamond CBD Pet CBD (cannabidiol) Product Portfolio Table 101. Diamond CBD Recent Development Table 102. Curaleaf Company Information Table 103. Curaleaf Business Overview Table 104. Curaleaf Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Curaleaf Pet CBD (cannabidiol) Product Portfolio Table 106. Curaleaf Recent Development Table 107. Choom Holdings Company Information Table 108. Choom Holdings Business Overview Table 109. Choom Holdings Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Choom Holdings Pet CBD (cannabidiol) Product Portfolio Table 111. Choom Holdings Recent Development Table 112. Canna-Pet Company Information Table 113. Canna-Pet Business Overview Table 114. Canna-Pet Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Canna-Pet Pet CBD (cannabidiol) Product Portfolio Table 116. Canna-Pet Recent Development Table 117. Cannabis Strategies Acquisition Company Information Table 118. Cannabis Strategies Acquisition Business Overview Table 119. Cannabis Strategies Acquisition Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Cannabis Strategies Acquisition Pet CBD (cannabidiol) Product Portfolio Table 121. Cannabis Strategies Acquisition Recent Development Table 122. Bluebird Botanicals Company Information Table 123. Bluebird Botanicals Business Overview Table 124. Bluebird Botanicals Pet CBD (cannabidiol) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. Bluebird Botanicals Pet CBD (cannabidiol) Product Portfolio Table 126. Bluebird Botanicals Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Pet CBD (cannabidiol) Distributors List Table 130. Pet CBD (cannabidiol) Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Pet CBD (cannabidiol) Product Image Figure 2. Global Pet CBD (cannabidiol) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet CBD (cannabidiol) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet CBD (cannabidiol) Sales (2021-2032) & (Tons) Figure 5. Global Pet CBD (cannabidiol) Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Pet CBD (cannabidiol) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. CBD Oil Image Figure 10. CBD Jelly Image Figure 11. CBD Capsule Image Figure 12. Other Image Figure 13. Global Pet CBD (cannabidiol) Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Pet CBD (cannabidiol) Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Pet CBD (cannabidiol) Sales Volume Share by Type (2021-2032) Figure 16. Global Pet CBD (cannabidiol) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pet CBD (cannabidiol) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pet CBD (cannabidiol) Sales Value Share by Type (2021-2032) Figure 19. Pet Sleep Disorder Image Figure 20. Pet Anxiety Image Figure 21. Pets Gastrointestinal Diseases Image Figure 22. Other Image Figure 23. Global Pet CBD (cannabidiol) Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Pet CBD (cannabidiol) Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Pet CBD (cannabidiol) Sales Volume Share by Application (2021-2032) Figure 26. Global Pet CBD (cannabidiol) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Pet CBD (cannabidiol) Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Pet CBD (cannabidiol) Sales Value Share by Application (2021-2032) Figure 29. Global Pet CBD (cannabidiol) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 30. Global Pet CBD (cannabidiol) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Pet CBD (cannabidiol) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Pet CBD (cannabidiol) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Pet CBD (cannabidiol) Sales Value (2021-2032) & (US$ Million) Figure 34. North America Pet CBD (cannabidiol) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Pet CBD (cannabidiol) Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Pet CBD (cannabidiol) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Pet CBD (cannabidiol) Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Pet CBD (cannabidiol) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Pet CBD (cannabidiol) Sales Value (2021-2032) & (US$ Million) Figure 40. South America Pet CBD (cannabidiol) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Pet CBD (cannabidiol) Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Pet CBD (cannabidiol) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Pet CBD (cannabidiol) Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Pet CBD (cannabidiol) Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • CBD Oil
  • CBD Jelly
  • CBD Capsule
  • Other
Applications
  • Pet Sleep Disorder
  • Pet Anxiety
  • Pets Gastrointestinal Diseases
  • Other
Companies covered
  • Trulieve Cannabis
  • Receptra Naturals
  • Pure Spectrum
  • PotNetwork Holdings
  • Pet Releaf
  • Kat's Naturals
  • Diamond CBD
  • Curaleaf
  • Choom Holdings
  • Canna-Pet
  • Cannabis Strategies Acquisition
  • Bluebird Botanicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet CBD (cannabidiol) Sales Value (2021-2032)
  4. 1.2.2 Global Pet CBD (cannabidiol) Sales Volume (2021-2032)
  5. 1.2.3 Global Pet CBD (cannabidiol) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet CBD (cannabidiol) Market Dynamics
  1. 2.1 Pet CBD (cannabidiol) Industry Trends
  2. 2.2 Pet CBD (cannabidiol) Industry Drivers
  3. 2.3 Pet CBD (cannabidiol) Industry Opportunities and Challenges
  4. 2.4 Pet CBD (cannabidiol) Industry Restraints
3 Pet CBD (cannabidiol) Market by Company
  1. 3.1 Global Pet CBD (cannabidiol) Company Revenue Ranking in 2025
  2. 3.2 Global Pet CBD (cannabidiol) Revenue by Company (2021-2026)
  3. 3.3 Global Pet CBD (cannabidiol) Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet CBD (cannabidiol) Average Price by Company (2021-2026)
  5. 3.5 Global Pet CBD (cannabidiol) Company Ranking (2024-2026)
  6. 3.6 Global Pet CBD (cannabidiol) Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet CBD (cannabidiol) Company Product Type and Application
  8. 3.8 Global Pet CBD (cannabidiol) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet CBD (cannabidiol) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet CBD (cannabidiol) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet CBD (cannabidiol) Market by Type
  1. 4.1 Pet CBD (cannabidiol) Type Introduction
  2. 4.1.1 CBD Oil
  3. 4.1.2 CBD Jelly
  4. 4.1.3 CBD Capsule
  5. 4.1.4 Other
  6. 4.2 Global Pet CBD (cannabidiol) Sales Volume by Type
  7. 4.2.1 Global Pet CBD (cannabidiol) Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pet CBD (cannabidiol) Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Pet CBD (cannabidiol) Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Pet CBD (cannabidiol) Sales Value by Type
  11. 4.3.1 Global Pet CBD (cannabidiol) Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pet CBD (cannabidiol) Sales Value by Type (2021-2032)
  13. 4.3.3 Global Pet CBD (cannabidiol) Sales Value Share by Type (2021-2032)
5 Pet CBD (cannabidiol) Market by Application
  1. 5.1 Pet CBD (cannabidiol) Application Introduction
  2. 5.1.1 Pet Sleep Disorder
  3. 5.1.2 Pet Anxiety
  4. 5.1.3 Pets Gastrointestinal Diseases
  5. 5.1.4 Other
  6. 5.2 Global Pet CBD (cannabidiol) Sales Volume by Application
  7. 5.2.1 Global Pet CBD (cannabidiol) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pet CBD (cannabidiol) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pet CBD (cannabidiol) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pet CBD (cannabidiol) Sales Value by Application
  11. 5.3.1 Global Pet CBD (cannabidiol) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pet CBD (cannabidiol) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pet CBD (cannabidiol) Sales Value Share by Application (2021-2032)
6 Pet CBD (cannabidiol) Regional Sales and Value Analysis
  1. 6.1 Global Pet CBD (cannabidiol) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet CBD (cannabidiol) Sales by Region (2021-2032)
  3. 6.2.1 Global Pet CBD (cannabidiol) Sales by Region: 2021-2026
  4. 6.2.2 Global Pet CBD (cannabidiol) Sales by Region (2027-2032)
  5. 6.3 Global Pet CBD (cannabidiol) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet CBD (cannabidiol) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet CBD (cannabidiol) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet CBD (cannabidiol) Sales Value by Region (2027-2032)
  9. 6.5 Global Pet CBD (cannabidiol) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet CBD (cannabidiol) Sales Value (2021-2032)
  12. 6.6.2 North America Pet CBD (cannabidiol) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet CBD (cannabidiol) Sales Value (2021-2032)
  15. 6.7.2 Europe Pet CBD (cannabidiol) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet CBD (cannabidiol) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet CBD (cannabidiol) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet CBD (cannabidiol) Sales Value (2021-2032)
  21. 6.9.2 South America Pet CBD (cannabidiol) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet CBD (cannabidiol) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet CBD (cannabidiol) Sales Value Share by Country, 2025 VS 2032
7 Pet CBD (cannabidiol) Country-level Sales and Value Analysis
  1. 7.1 Global Pet CBD (cannabidiol) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet CBD (cannabidiol) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet CBD (cannabidiol) Sales by Country (2021-2032)
  4. 7.3.1 Global Pet CBD (cannabidiol) Sales by Country (2021-2026)
  5. 7.3.2 Global Pet CBD (cannabidiol) Sales by Country (2027-2032)
  6. 7.4 Global Pet CBD (cannabidiol) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet CBD (cannabidiol) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet CBD (cannabidiol) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet CBD (cannabidiol) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet CBD (cannabidiol) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet CBD (cannabidiol) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Trulieve Cannabis
  2. 8.1.1 Trulieve Cannabis Company Information
  3. 8.1.2 Trulieve Cannabis Business Overview
  4. 8.1.3 Trulieve Cannabis Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Trulieve Cannabis Pet CBD (cannabidiol) Product Portfolio
  6. 8.1.5 Trulieve Cannabis Recent Developments
  7. 8.2 Receptra Naturals
  8. 8.2.1 Receptra Naturals Company Information
  9. 8.2.2 Receptra Naturals Business Overview
  10. 8.2.3 Receptra Naturals Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Receptra Naturals Pet CBD (cannabidiol) Product Portfolio
  12. 8.2.5 Receptra Naturals Recent Developments
  13. 8.3 Pure Spectrum
  14. 8.3.1 Pure Spectrum Company Information
  15. 8.3.2 Pure Spectrum Business Overview
  16. 8.3.3 Pure Spectrum Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pure Spectrum Pet CBD (cannabidiol) Product Portfolio
  18. 8.3.5 Pure Spectrum Recent Developments
  19. 8.4 PotNetwork Holdings
  20. 8.4.1 PotNetwork Holdings Company Information
  21. 8.4.2 PotNetwork Holdings Business Overview
  22. 8.4.3 PotNetwork Holdings Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 PotNetwork Holdings Pet CBD (cannabidiol) Product Portfolio
  24. 8.4.5 PotNetwork Holdings Recent Developments
  25. 8.5 Pet Releaf
  26. 8.5.1 Pet Releaf Company Information
  27. 8.5.2 Pet Releaf Business Overview
  28. 8.5.3 Pet Releaf Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pet Releaf Pet CBD (cannabidiol) Product Portfolio
  30. 8.5.5 Pet Releaf Recent Developments
  31. 8.6 Kat's Naturals
  32. 8.6.1 Kat's Naturals Company Information
  33. 8.6.2 Kat's Naturals Business Overview
  34. 8.6.3 Kat's Naturals Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kat's Naturals Pet CBD (cannabidiol) Product Portfolio
  36. 8.6.5 Kat's Naturals Recent Developments
  37. 8.7 Diamond CBD
  38. 8.7.1 Diamond CBD Company Information
  39. 8.7.2 Diamond CBD Business Overview
  40. 8.7.3 Diamond CBD Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Diamond CBD Pet CBD (cannabidiol) Product Portfolio
  42. 8.7.5 Diamond CBD Recent Developments
  43. 8.8 Curaleaf
  44. 8.8.1 Curaleaf Company Information
  45. 8.8.2 Curaleaf Business Overview
  46. 8.8.3 Curaleaf Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Curaleaf Pet CBD (cannabidiol) Product Portfolio
  48. 8.8.5 Curaleaf Recent Developments
  49. 8.9 Choom Holdings
  50. 8.9.1 Choom Holdings Company Information
  51. 8.9.2 Choom Holdings Business Overview
  52. 8.9.3 Choom Holdings Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Choom Holdings Pet CBD (cannabidiol) Product Portfolio
  54. 8.9.5 Choom Holdings Recent Developments
  55. 8.10 Canna-Pet
  56. 8.10.1 Canna-Pet Company Information
  57. 8.10.2 Canna-Pet Business Overview
  58. 8.10.3 Canna-Pet Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Canna-Pet Pet CBD (cannabidiol) Product Portfolio
  60. 8.10.5 Canna-Pet Recent Developments
  61. 8.11 Cannabis Strategies Acquisition
  62. 8.11.1 Cannabis Strategies Acquisition Company Information
  63. 8.11.2 Cannabis Strategies Acquisition Business Overview
  64. 8.11.3 Cannabis Strategies Acquisition Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Cannabis Strategies Acquisition Pet CBD (cannabidiol) Product Portfolio
  66. 8.11.5 Cannabis Strategies Acquisition Recent Developments
  67. 8.12 Bluebird Botanicals
  68. 8.12.1 Bluebird Botanicals Company Information
  69. 8.12.2 Bluebird Botanicals Business Overview
  70. 8.12.3 Bluebird Botanicals Pet CBD (cannabidiol) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bluebird Botanicals Pet CBD (cannabidiol) Product Portfolio
  72. 8.12.5 Bluebird Botanicals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet CBD (cannabidiol) Value Chain Analysis
  2. 9.1.1 Pet CBD (cannabidiol) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet CBD (cannabidiol) Sales Mode & Process
  6. 9.2 Pet CBD (cannabidiol) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet CBD (cannabidiol) Distributors
  9. 9.2.3 Pet CBD (cannabidiol) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst